Giustina, A., di Filippo, L., Facciorusso, A., Adler, R. A., Binkley, N., Bollerslev, J., Bouillon, R., Casanueva, F. F., Cavestro, G. M., Chakhtoura, M., Conte, C., Donini, L. M., Ebeling, P. R., Fassio, A., Frara, S., Gagnon, C., Latella, G., Marcocci, C., Mechanick, J. I., … Bilezikian, J. P. (2023). Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis. Reviews in Endocrine and Metabolic Disorders, 24(6), 1011–1029. https://doi.org/10.1007/s11154-023-09831-3

Chandran, M., Yeh, L. T. L., de Jong, M. C., Bilezikian, J. P., & Parameswaran, R. (2022). Cognitive deficits in primary hyperparathyroidism – what we know and what we do not know: A narrative review. Reviews in Endocrine and Metabolic Disorders, 23(5), 1079–1087. https://doi.org/10.1007/s11154-022-09750-9

Driggin, E., Madhavan, M. V., & Gupta, A. (2022). The role of vitamin D in cardiovascular disease and COVID-19. Reviews in Endocrine and Metabolic Disorders, 23(2), 293–297. https://doi.org/10.1007/s11154-021-09674-w

Giustina, A., & Bilezikian, J. P. (2022). Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic. Reviews in Endocrine and Metabolic Disorders, 23(2), 133–136. https://doi.org/10.1007/s11154-022-09716-x

Chandran, M., Bilezikian, J. P., Lau, J., Rajeev, R., Yang, S. P., Samuel, M., & Parameswaran, R. (2022). The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies. Reviews in Endocrine and Metabolic Disorders, 23(3), 485–501. https://doi.org/10.1007/s11154-021-09694-6

Bilezikian, J. P., Formenti, A. M., Adler, R. A., Binkley, N., Bouillon, R., Lazaretti-Castro, M., Marcocci, C., Napoli, N., Rizzoli, R., & Giustina, A. (2021). Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all? Reviews in Endocrine and Metabolic Disorders, 22(4), 1201–1218. https://doi.org/10.1007/s11154-021-09693-7